Table 1.
Patient Demographics and Clinical Characteristics
| Characteristic | |||
|---|---|---|---|
| Implant type | Responsive | SoftTouch | Cohesive |
| No. of patients | 52 | 24 | 53 |
| Mean age, in years (range, SD) | 48 (27-68, 11) | 47 (33-73, 9) | 49 (31-68, 10) |
| Mean BMI (range, SD) | 25.33 (16.45-38.00, 4.86) | 25.78 (18.80-38.40, 6.17) | 25.08 (17.70-39.30, 4.40) |
| Mean follow-up, in days (range, SD) | 468 (187-1130, 230) | 417 (186-901, 183) | 478 (181-930, 227) |
| Race, n (%) | |||
| White | 46 (88.5) | 22 (91.7) | 46 (86.8) |
| Black | 1 (1.9) | 0 (0.0) | 3 (5.7) |
| Asian | 1 (1.9) | 0 (0.0) | 3 (5.7) |
| Other | 1 (1.9) | 2 (8.3) | 1 (1.9) |
| Unknown | 3 (5.8) | 0 (0.0) | 0 (0.0) |
| Ethnicity, n (%) | |||
| Hispanic | 0 (0.0) | 1 (4.2) | 0 (0.0) |
| Non-Hispanic | 51 (98.1) | 22 (91.7) | 50 (94.3) |
| Unknown | 1 (1.9) | 1 (4.2) | 3 (5.7) |
| Hypertension, n (%) | 14 (26.9) | 3 (12.5) | 4 (7.5) |
| Diabetes, n (%) | 2 (3.8) | 0 (0.0) | 3 (5.7) |
| Smoker, n (%) | |||
| Active | 0 (0.0) | 0 (0.0) | 3 (5.7) |
| Former | 14 (26.9) | 2 (8.3) | 14 (26.4) |
| Never | 38 (73.1) | 22 (91.7) | 35 (66.0) |
| Unknown | 0 (0.0) | 0 (0.0) | 1 (1.9) |
| Mean implant size, in cc (range, SD) | 449 (140-770, 147) | 413 (145-775, 164) | 410 (175-770, 136) |
| Acellular dermal matrix placement, n (%) | 51 (98.1) | 24 (100) | 53 (100) |
| Rippling following implant placement, n (%) | 21 (40.4) | 4 (16.7) | 11 (20.8) |
| Fat grafting after implant placement, n (%) | 11 (21.2) | 2 (8.3) | 1 (1.9) |
| Rippling resolved with fat grafting, n (%) | 4 (7.7) | 0 (0.0) | 0 (0.0) |
| Infection after tissue expander placement, n (%) | 3 (5.8) | 0 (0.0) | 1 (1.9) |
| Infection after breast implant placement, n (%) | 4 (7.7) | 0 (0.0) | 1 (1.9) |
| Capsular contracture, n (%) | 4 (7.7) | 0 (0.0) | 0 (0.0) |